Related Experiment Video
Updated: Nov 5, 2025

11:11
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
Published on: February 11, 2022
4.7K
A Multiplex One-Step RT-qPCR Protocol to Detect SARS-CoV-2 in NP/OP Swabs and Saliva
Joshua Bland1, Ashley Kavanaugh1, Lenny K Hong1
1Department of Pathology, University of Illinois at Chicago, Chicago, Illinois.
Current Protocols
|May 18, 2021
Summary
A new multiplex reverse-transcription real-time PCR assay detects SARS-CoV-2 in various specimen types, including saliva and nasal swabs, simplifying testing. This cost-effective method enhances diagnostic flexibility and reduces laboratory setup costs for widespread virus detection.
Area of Science:
- Molecular Biology
- Virology
- Infectious Diseases
Background:
- The global spread of SARS-CoV-2 necessitates accurate and accessible diagnostic methods.
- Current molecular tests for SARS-CoV-2 RNA often have restrictive specimen collection requirements, limiting their application.
- Variations in specimen types (nasopharyngeal/oropharyngeal swabs, saliva) and collection media (VTM, saline) complicate laboratory validation and increase costs.
Purpose of the Study:
- To develop and validate a cost-effective multiplex reverse-transcription real-time PCR (RT-qPCR) assay for SARS-CoV-2 detection.
- To create a versatile assay capable of analyzing diverse specimen types and collection media.
- To streamline laboratory workflows for SARS-CoV-2 diagnostics.
Main Methods:
- Development and validation of a multiplex RT-qPCR assay for detecting SARS-CoV-2.
- Testing the assay's performance with nasopharyngeal/oropharyngeal swabs and saliva samples.
- Evaluation of different collection media, including viral transport medium (VTM), saline, and preservative fluid.
- Description of optimal laboratory setup and unidirectional workflow for RT-qPCR.
Main Results:
- The developed multiplex RT-qPCR assay demonstrated high sensitivity and specificity for SARS-CoV-2 detection.
- The assay successfully detected viral RNA in both saliva and nasopharyngeal/oropharyngeal swabs collected in various media.
- The single assay accommodates multiple specimen types and collection media, simplifying laboratory procedures.
Conclusions:
- The validated multiplex RT-qPCR assay offers a cost-effective and flexible solution for SARS-CoV-2 detection.
- This unified approach reduces the need for multiple test validations, saving costs and infrastructure.
- The assay supports diverse specimen types and collection media, enhancing diagnostic accessibility and efficiency.

